Increased cellularity, mitotic rate (>5/50 HPFs) and Ki-67 labeling index (>10%), necrosis, cyst formation and tumor size are parameters for evaluating GISTs, of which the first three are predictors of poor prognosis[21,22]. This evidence concerns the gene MKI67 and neoplasm.